Figure 2: Active pharmacological intervention trials in TNBC.

Crosstalk Between Triple Negative Breast Cancer and Microenvironment

“[...] the study of immunotherapy for treating triple negative breast cancer might still be at its early stages of development but is full of future promise.”  Listen to an audio… read more